Panel Discussion: What are the Future Directions of the Inflammasome Therapeutics Landscape? A Glimpse into the Next 5 Years
Time: 2:30 pm
day: Day 2
Details:
- Reflecting on all the incredible insights shared today and our key takings, where do we see the inflammasome landscape going?
- Does commercial opportunity lie in tackling metabolic diseases or even with combination therapies?
- What is the feasibility and efficacy of targeting alternative inflammasomes across diverse disease sets?
- Discuss the areas of unmet needs with opportunity to be addressed by emerging therapeutics and modalities
